| 000 | 01862cam a22003255i 4500 | ||
|---|---|---|---|
| 001 | 22664840 | ||
| 003 | OSt | ||
| 005 | 20230607120220.0 | ||
| 008 | 220624s2023 nyu 000 0 eng | ||
| 010 | _a 2022941535 | ||
| 020 |
_a9780198746409 _q(paperback) |
||
| 020 | _z9780191063466 | ||
| 020 |
_z9780191063473 _q(epub) |
||
| 020 | _z9780191808470 | ||
| 040 |
_aDLC _beng _erda _cDLC |
||
| 042 | _apcc | ||
| 100 | 1 |
_aDickman, Andrew, _eauthor. |
|
| 245 | 1 | 0 |
_aDrugs in palliative care / _cAndrew Dickman. |
| 250 | _a3. | ||
| 264 | 1 |
_aNew York : _bOxford University Press, _c2023. |
|
| 300 | _apages cm | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 0 | _aDrugs in series paper | |
| 520 |
_a"While palliative care has adopted a holistic approach to treatment, medication driven symptom management ostensibly forms the critical aspect of care. Prescribing in palliative care can be extremely complex because the patient may often have comorbidity, or occasionally multimorbidity. The associated polypharmacy further complicates the pharmacological management of symptoms being caused by the palliative condition. This can be daunting for healthcare professionals and can negatively impact upon the effectiveness of care provided. Fully revised and updated, the third edition of Drugs in Palliative and Supportive Care provides a detailed yet concise overview of topics that are encountered in palliative care clinical practice. The book will appeal to a variety of healthcare professionals involved in the provision of palliative care and medicines information"-- _cProvided by publisher. |
||
| 906 |
_a0 _bibc _corignew _d2 _eepcn _f20 _gy-gencatlg |
||
| 942 |
_2lcc _cBK _n0 |
||
| 999 |
_c2919 _d2919 |
||